Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19

The Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was identified in December 2019. The symptoms include fever, cough, dyspnea, early symptom of sputum, and acute respiratory distress syndrome (ARDS). Mesenchymal stem cell (MSC) therapy is the immediate treatment used for patients with sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Lingling, Jiang, Yingan, Zhu, Mengfei, Chen, Lijun, Zhou, Xiaoyang, Zhou, Chenliang, Ye, Peng, Chen, Xiaobei, Wang, Baohong, Xu, Zhenyu, Zhang, Qiang, Xu, Xiaowei, Gao, Hainv, Wu, Xiaojun, Li, Dong, Jiang, Wanli, Qu, Jingjing, Xiang, Charlie, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2020
Materias:
Letter to Frontiers of Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406954/
https://www.ncbi.nlm.nih.gov/pubmed/32761491
http://dx.doi.org/10.1007/s11684-020-0810-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406954/
https://www.ncbi.nlm.nih.gov/pubmed/32761491
http://dx.doi.org/10.1007/s11684-020-0810-9

Ejemplares similares